Present address: Laboratoire d'Oncogénèse Immunohématologique, Institut de Biologie, 9 quai Moncousu, 44035 Nantes, France.
Cytokine gene expression in human multiple myeloma
Article first published online: 12 MAR 2008
British Journal of Haematology
Volume 85, Issue 3, pages 514–520, November 1993
How to Cite
Portier, M., Zhang, X.-G., Ursule, E., Lees, D., Jourdan, M., Bataille, R. and Klein, B. (1993), Cytokine gene expression in human multiple myeloma. British Journal of Haematology, 85: 514–520. doi: 10.1111/j.1365-2141.1993.tb03341.x
- Issue published online: 12 MAR 2008
- Article first published online: 12 MAR 2008
- Received 9 February 1993; accepted for publication 2 June 1993
Summary. In the present study the gene expression of cytokines promoting in vitro myeloma-cell growth was investigated by Northern blot analysis using total RNA of 36 tumour samples of patients with multiple myeloma (MM) or plasma cell leukaemia and poly(A)+ RNA of 10 human myeloma cell lines (HMCL). These cytokines included interleukin (IL)-1α, IL-1β, IL-3, IL-6, granulocyte-macrophage (GM)-colony-stimulating factor (CSF) and granulocyte (G)-CSF. IL-1β, IL-6 and G-CSF genes were coexpressed in most patients, although at variable levels. IL-1α transcripts were detected in 32% of patients in whom coexpression of IL-1β gene was found. IL-3 gene was not expressed in patients' cells and GM-CSF mRNA was detected in only 1/32 patients. No detectable transcripts for the above cytokines were present in HMCL, whereas IL-6 gene was expressed in 2/10 HMCL.
We also looked for the presence of transcripts for IL-2, leukaemia inhibitory factor (LIF) and transforming growth factor (TGF)β in cells of tumour samples from the same patients and in HMCL. IL-2 gene was not expressed in MM patients and HMCL. Weak expression of LIF gene was detected in three patients (9%), and transforming growth factor β (TGFβ) mRNA was observed in 12/12 tumour samples analysed and all HMCL.
These results suggest that, among cytokines shown to control myeloma-cell growth in vitro, IL-1, IL-6 and G-CSF could play a role in the development of myeloma disease in vivo.